This Curriculum is supported by an educational grant from



Educational materials developed
by and produced by Projects In Knowledge, Incorporated.
 

Vol. 1, Issue 2

The Curriculum in Iron Metabolism & Related Disorders

Co-Chair


Photis Beris, MD, PhD

Pierre Brissot, MD

Maria D. Cappellini, MD

The Curriculum in Iron Metabolism & Related Disorders now offers a total of 14 informative and free courses for busy haematologists and other clinicians who care for patients with iron metabolism–related disorders. Descriptions of the newly added courses are presented below.

Now you can earn a Certificate of Advanced Study! To earn a certificate, complete and submit a posttest for a minimum of 10 courses.

We look forward to your continued participation. If you have not yet enrolled, visit our website today for enrollment information and to learn more about this important educational opportunity:
www.ironcurriculum.esh.org

Newly Added Courses

Epidemiology and Pathophysiology: Myelodysplastic Syndromes
“Myelodysplastic Syndromes: Review of Pathophysiology and Current Novel Treatment Approaches,” by E.D. Warlick and B.D. Smith. Current Cancer Drug Targets. 2007;7:541-558.
Delivered via: Online Chapter Reprint

Iron Deficiency: Clinical Sequelae and Diagnosis
Photis Beris, MD, reviews pathogenesis, symptoms and signs, and diagnosis of iron-deficiency anaemia, the most common nutritional deficiency worldwide.
Delivered via: Webcast with Downloadable Slides

Diagnosis of Iron Overload
Maria Domenica Cappellini, MD, examines the advantages and disadvantages of various methods of assessing iron overload and how best to utilize test results in managing patients.
Delivered via: Webcast with Downloadable Slides

Iron Chelation Basics
John B. Porter, MA, MD, FRCP, outlines the goals and mechanisms of chelation therapy, as well as the advantages and disadvantages of desferrioxamine, deferiprone, and deferasirox.
Delivered via: Webcast with Downloadable Slides

Indications for Successful Iron Overload Treatments and Monitoring: Hereditary Haemochromatosis
Pierre Brissot, MD, discusses the use of phlebotomy and iron chelation for the treatment of HFE and non-HFE haemochromatosis, including the indications, administration, benefits, and limitations of both options.
Delivered via: Webcast with Downloadable Slides

Indications for Successful Iron Overload Treatments and Monitoring: Thalassaemia
Maria Domenica Cappellini, MD, reviews expert recommendations for the initiation and monitoring of chelation therapy to treat thalassaemia, as well as what to consider when the need to switch therapy arises.
Delivered via: Webcast with Downloadable Slides

Iron Toxicity and Clinical Sequelae
John B. Porter, MA, MD, FRCP, discusses iron overload: risk factors, mechanisms contributing to its development, and resulting clinical consequences on the liver, heart, and endocrine system.
Delivered via: Webcast with Downloadable Slides

Indications for Successful Iron Overload Treatments and Monitoring: Sickle Cell Disease
Mariane de Montalembert, MD, examines the problem of iron overload in patients with sickle cell disease and offers expert guidance on maintaining iron balance through safe and effective use of chelating agents.
Delivered via: Webcast with Downloadable Slides

Indications for Successful Iron Overload Treatments and Monitoring—Myelodysplastic Syndromes
Featuring Norbert Gattermann, MD, PhD discusses indications for and benefits of chelation therapy, selection of appropriate MDS patients for treatments and treatments guidelines for the initiation and duration of iron chelation therapy.
Delivered via: Webcast with Downloadable Slides

Ongoing Courses

End-Organ Damage Resulting from Accumulation of Iron in Cells
Featuring Pierre Brissot, MD
Delivered via: Webcast with Downloadable Slides

Epidemiology and Disease Pathophysiology: Thalassaemia
Featuring Ali T. Taher, MD
Delivered via: Webcast with Downloadable Slides

Epidemiology and Disease Pathophysiology: Hereditary Haemochromatosis
Featuring Pierre Brissot, MD
Delivered via: Webcast with Downloadable Slides

Epidemiology and Disease Pathophysiology: Other Anaemias
Featuring Ali T. Taher, MD
Delivered via: Webcast with Downloadable Slides

Epidemiology and Disease Pathophysiology: Sickle Cell Disease
Delivered via: Online Book Chapter

Visit our website, www.ironcurriculum.esh.org, for full program details and faculty disclosure information.

1798MU-2